Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Swiss researchers analyzed shifts in kidney function among those switching from the old form of the HIV medication to the new one.
Gilead Sciences has released multiple combo tablets that contain the updated tenofovir, which is linked to improved bone and kidney makers.
Nevertheless, researchers advise careful kidney monitoring when pairing the medications.
The once-daily regimen includes the integrase inhibitor bictegravir plus the contents of Descovy (emtricitabine/tenofovir alafenamide).
Regardless of whether individuals have hepatitis B or C, the improvement tends to occur quickly.
A 96-week study also found that switching from Viread to Vemlidy led to improvements in liver enzyme levels.
An updated version of Viread, called TAF, combats hepatitis B as effectively as the older drug and is safer for bone and kidney health.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.